×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AURA – aura biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
04:01 pm
aura
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Medium
Report
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
3/24
09:36 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
3/24
07:00 am
aura
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
Medium
Report
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
3/3
07:07 am
aura
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress [Yahoo! Finance]
Medium
Report
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress [Yahoo! Finance]
3/3
07:00 am
aura
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
Medium
Report
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
2/25
07:00 am
aura
Aura Biosciences to Participate in Upcoming Investor Conferences
Low
Report
Aura Biosciences to Participate in Upcoming Investor Conferences
2/1
05:58 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/24
05:16 pm
aura
Form S-8 Aura Biosciences, Inc.
Low
Report
Form S-8 Aura Biosciences, Inc.
3/24
05:01 pm
aura
Form 10-K Aura Biosciences, Inc. For: Dec 31
Low
Report
Form 10-K Aura Biosciences, Inc. For: Dec 31
3/24
04:01 pm
aura
Form 8-K Aura Biosciences, Inc. For: Mar 24
Medium
Report
Form 8-K Aura Biosciences, Inc. For: Mar 24
2/18
07:32 pm
aura
Form 144 Aura Biosciences, Inc. Filed by: Elazzouzi Amy
Neutral
Report
Form 144 Aura Biosciences, Inc. Filed by: Elazzouzi Amy
2/18
07:32 pm
aura
Form 144 Aura Biosciences, Inc. Filed by: Hopkins Janet Jill
Neutral
Report
Form 144 Aura Biosciences, Inc. Filed by: Hopkins Janet Jill
2/18
07:32 pm
aura
Form 144 Aura Biosciences, Inc. Filed by: de los Pinos Elisabet
Neutral
Report
Form 144 Aura Biosciences, Inc. Filed by: de los Pinos Elisabet
2/18
07:32 pm
aura
Form 144 Aura Biosciences, Inc. Filed by: Plavsic Mark
Neutral
Report
Form 144 Aura Biosciences, Inc. Filed by: Plavsic Mark
2/18
07:31 pm
aura
Form 4 Aura Biosciences, Inc. For: Feb 18 Filed by: Hopkins Janet Jill
Neutral
Report
Form 4 Aura Biosciences, Inc. For: Feb 18 Filed by: Hopkins Janet Jill
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: